Want to join the conversation?
$BDX 3Q15 Call: Pricing was about flat on a legacy BD basis. YTD pricing is better than our expectations,& as such we are revising our full year guidance for pricing to be about flat YoverY. BD Medical third quarter revenues increased 1.6%. Underlying medical revenue growth was approx. 4%, which includes normalizing for tough comparison in Infusion
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!